New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity

被引:87
作者
Dzubak, Petr
Hajdúch, Marian
Gazak, Radek
Svobodova, Alena
Psotova, Jitka
Walterova, Daniela
Sedmera, Petr
Kren, Vladimir
机构
[1] Acad Sci Czech Republ, Inst Microbiol, CZ-14220 Prague, Czech Republic
[2] Palacky Univ, Fac Med, Dept Paediat, Expt Med Lab, CZ-77520 Olomouc, Czech Republic
[3] Univ Hosp Olomouc, CZ-77520 Olomouc, Czech Republic
[4] Palacky Univ, Fac Med, Inst Med Biochem & Chem, CZ-77515 Olomouc, Czech Republic
关键词
silymarin; silybin; dehydrosilybin; P-glycoprotein inhibition; cancerostatic;
D O I
10.1016/j.bmc.2006.01.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Large series of O-alkyl derivatives (methyl and benzyl) of silybin and 2,3-dehydrosilybin was prepared. Selective alkylation of the silybin molecule was systematically investigated. For the first time we present here, for example, preparation of 19-nor-2,3-dehydrosilybin. All prepared silybin/2.3-dehydrosilybin derivatives were tested for cytotoxicity on a panel of drugs sensitive against multidrug resistant cell lines and the ability to inhibit P-glycoprotein mediated efflux activity. We have identified effective and relatively non-cytotoxic inhibitors of P-gp derived from 2,3-dehydrosilybin. Some of them were more effective inhibitors at concentrations lower than a standard P-gp efflux inhibitor cyclosporin A. Another group of 2,3-dehydrosilybin derivatives also had better inhibitory effects on P-gp efflux but a cytotoxicity comparable with that of parent 2,3-dehydrosilybin. Structural requirements for improving inhibitory activity and reducing toxicity of 2,3-dehydrosilybin were established. Effect of E-ring substitution as well as an influence of the substituent size at the C-7-OH position of A-ring on P-gp-inhibitory activity was evaluated for the first time in this study. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3793 / 3810
页数:18
相关论文
共 50 条
[1]
Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression [J].
Ahmad, N ;
Gali, H ;
Javed, S ;
Agarwal, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :294-301
[2]
ANTUS S, 1989, LIEBIGS ANN CHEM, P1147
[3]
Bhatia N, 2001, PROSTATE, V46, P98
[4]
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity [J].
Bokemeyer, C ;
Fels, LM ;
Dunn, T ;
Voigt, W ;
Gaedeke, J ;
Schmoll, HJ ;
Stolte, H ;
Lentzen, H .
BRITISH JOURNAL OF CANCER, 1996, 74 (12) :2036-2041
[5]
Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein [J].
Conseil, G ;
Baubichon-Cortay, H ;
Dayan, G ;
Jault, JM ;
Barron, D ;
Di Pietro, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :9831-9836
[6]
de Groot H, 1998, FUND CLIN PHARMACOL, V12, P249
[7]
Silibinin inhibits constitutive and TNFα-induced activation of NF-αB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis [J].
Dhanalakshmi, S ;
Singh, RP ;
Agarwal, C ;
Agarwal, R .
ONCOGENE, 2002, 21 (11) :1759-1767
[8]
Role of chemopreventive agents in cancer therapy [J].
Dorai, T ;
Aggarwal, BB .
CANCER LETTERS, 2004, 215 (02) :129-140
[9]
Flavonoid-related modulators of multidrug resistance:: Synthesis, pharmacological activity, and structure-activity relationships [J].
Ferté, J ;
Kühnel, JM ;
Chapuis, G ;
Rolland, Y ;
Lewin, G ;
Schwaller, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) :478-489
[10]
Milk thistle (Silybum marianum) for the therapy of liver disease [J].
Flora, K ;
Hahn, M ;
Rosen, H ;
Benner, K .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143